Medicine Description eylea 40mg
eylea 40mg Ampoules is a medication that contains aflibercept, a fusion protein that acts as a vascular endothelial growth factor (VEGF) inhibitor. It binds to VEGF-A and placental growth factor (PlGF), preventing them from interacting with their receptors on the surface of endothelial cells. This inhibition reduces the formation of new blood vessels (angiogenesis) and decreases vascular permeability, effectively addressing pathological conditions associated with abnormal blood vessel growth and leakage in the retina. By blocking these factors, eylea helps to stabilize vision and improve overall retinal health in patients suffering from various retinal diseases.
Indications and Uses of eylea 40mg Ampoules
- Wet age-related macular degeneration (AMD)
- Diabetic macular edema (DME)
- Diabetic retinopathy in patients with DME
- Macular edema following retinal vein occlusion (RVO)
Side Effects of eylea 40mg Ampoules
- Eye discomfort or irritation
- Increased intraocular pressure
- Conjunctival hemorrhage
- Retinal detachment
- Vision changes
Storage and Handling
eylea 40mg Ampoules should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F). It must be protected from light and should not be frozen. Once removed from the refrigerator, it can be stored at room temperature for a limited time, but should be used promptly to ensure efficacy.
Patient Advice and Precautions
Patients should be informed about the potential side effects and the importance of regular follow-up appointments with their healthcare provider. It is crucial to ensure that the medication is administered by a qualified professional under sterile conditions. Patients should report any sudden changes in vision or eye discomfort promptly, and they should avoid self-administering the injection.